Journey Medical Corporation Enters into a Definitive Agreement with Dermira, Inc., a Wholly-Owned Subsidiary of Eli Lilly and Company, to Acquire QBREXZA®GlobeNewsWire • 04/01/21
Fortress Biotech Reports Record 2020 Financial Results and Recent Corporate HighlightsGlobeNewsWire • 03/31/21
Fortress Biotech's Partner Company, Journey Medical Corporation, In-licenses and Launches Accutane® for the Treatment of Severe Recalcitrant Nodular AcneGlobeNewsWire • 03/22/21
Will Fortress Biotech (FBIO) Report Negative Q4 Earnings? What You Should KnowZacks Investment Research • 03/08/21
Caelum Biosciences Announces Collaborations with the Amyloidosis Advocacy Community and Support of Amyloidosis Awareness MonthGlobeNewsWire • 03/01/21
Fortress Biotech Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day®GlobeNewsWire • 02/26/21
Aevitas Therapeutics Appoints Markus Peters, Ph.D., M.Sc., as Chief Executive OfficerGlobeNewsWire • 02/22/21
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Fortress Biotech, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 01/26/21
DEADLINE TOMORROW: The Schall Law Firm Announces it is Investigating Claims Against Fortress Biotech, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 01/25/21
FBIO Final Deadline Tomorrow: Rosen, National Trial Lawyers, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action - FBIONewsfile Corp • 01/25/21
FBIO FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important Tuesday Deadline in Securities Class Action - FBIOPRNewsWire • 01/23/21
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO)Business Wire • 01/22/21
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPRNewsWire • 01/22/21
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline - FBIONewsfile Corp • 01/21/21
Rosen, Leading Trial Attorneys, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action - FBIONewsfile Corp • 01/19/21
ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - FBIONewsfile Corp • 01/11/21
ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - FBIOPRNewsWire • 01/09/21
ROSEN, TOP RANKED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action - FBIONewsfile Corp • 01/06/21
Fortress Biotech to Participate in Three January 2021 Virtual Investor ConferencesGlobeNewsWire • 01/05/21
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPRNewsWire • 12/30/20
ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action - FBIOBusiness Wire • 12/29/20
ROSEN, A TOP RANKED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FBIONewsfile Corp • 12/26/20
